Recombinant disintegrin domain of ADAM15 inhibits the proliferation and migration of Bel-7402 cells

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 640-645

  Hou, Y ^a   Chu, M ^a   Du, F F ^a   Lei, J Y ^a   Chen, Y ^a   Zhu, R Y ^a   Gong, X H ^a   Ma, X ^a   Jin, J ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

ADAM15; Bel 7402 cells; Disintegrin; Migration; Proliferation; Zebrafish

Indexed keywords

ADAM PROTEIN; ADAM15 PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; DISINTEGRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; ZEBRA FISH;

ADAM PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISINTEGRINS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

DANIO RERIO;

EID: 84878973896     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.037     Document Type: Article

References (29)

1. Zhang Y.Y., Chen B., Ding Y.Q. Metastasis-associated factors facilitating the progression of colorectal cancer. Asian Pac. J. Cancer Prev. 2012, 13:2437-2444.
2. Anastassiou G., Duensing S., Steinhoff G., Kirchner H., Ganser A., Atzpodien J. In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasis. Cancer Biother. 1995, 10:287-292.
3. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
4. Li D.J. Research progress of integrins and RGD sequence in the field of blood. Int. J. Blood. Transfus. Hematol. 2002, 23:3.
5. White J.M. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol. 2003, 15:598-606.
6. Mochizuki S., Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007, 98:621-628.
7. Wolfsberg T.G., Primakoff P., Myles D.G., White J.M. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 1995, 131:275-278.
8. Komiya K., Enomoto H., Inoki I., Okazaki S., Fujita Y., Ikeda E., Ohuchi E., Matsumoto H., Toyama Y., Okada Y. Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis. Arthritis Res. Ther. 2005, 7:R1158-R1173.
9. Schutz A., Hartig W., Wobus M., Grosche J., Wittekind C., Aust G. Expression of ADAM15 in lung carcinomas. Virchows Arch. 2005, 446:421-429.
10. Kuefer R., Day K.C., Kleer C.G., Sabel M.S., Hofer M.D., Varambally S., Zorn C.S., Chinnaiyan A.M., Rubin M.A., Day M.L. ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease. Neoplasia 2006, 8:319-329.
11. Arribas J., Bech-Serra J.J., Santiago-Josefat B. ADAMs, cell migration and cancer. Cancer Metastasis Rev. 2006, 25:57-68.
12. Zhang X.P., Kamata T., Yokoyama K., Puzon-McLaughlin W., Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J. Biol. Chem. 1998, 273:7345-7350.
13. Eto K., Puzon-McLaughlin W., Sheppard D., Sehara-Fujisawa A., Zhang X.P., Takada Y. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J. Biol. Chem. 2000, 275:34922-34930.
14. Herren B., Garton K.J., Coats S., Bowen-Pope D.F., Ross R., Raines E.W. ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions. Exp. Cell Res. 2001, 271:152-160.
15. Najy A.J., Day K.C., Day M.L. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction. Cancer Res. 2008, 68:1092-1099.
16. Trochon-Joseph V., Martel-Renoir D., Mir L.M., Thomaidis A., Opolon P., Connault E., Li H., Grenet C., Fauvel-Lafeve F., Soria J., Legrand C., Soria C., Perricaudet M., Lu H. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res. 2004, 64:2062-2069.
17. Wu J., Lei J., Zhang L., Hua H., Jin J. Improving production and bioactivity of recombinant human disintegrin domain of ADAM15 (rhADAM15) in Escherichia coli. Wei Sheng Wu Xue Bao 2008, 48:1067-1074.
18. Wu J., Zhang L., Lei J., Cai G., Zhu W., Lu D., Jin J. Enhancement of recombinant human ADAM15 disintegrin domain expression level by releasing the rare codons and amino acids restriction. Appl. Biochem. Biotechnol. 2009, 157:299-310.
19. Cole L.K., Ross L.S. Apoptosis in the developing zebrafish embryo. Dev. Biol. 2001, 240:123-142.
20. Lee S.L., Rouhi P., Dahl Jensen L., Zhang D., Ji H., Hauptmann G., Ingham P., Cao Y. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc. Natl. Acad. Sci. USA 2009, 106:19485-19490.
21. Halpern M.E., Thisse C., Ho R.K., Thisse B., Riggleman B., Trevarrow B., Weinberg E.S., Postlethwait J.H., Kimmel C.B. Cell-autonomous shift from axial to paraxial mesodermal development in zebrafish floating head mutants. Development 1995, 121:4257-4264.
22. Eliceiri B.P., Cheresh D.A. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 1999, 103:1227-1230.
23. Yang S.J., Meng J.P., Qu Y., Liu Y.B. The progress on the signal transduction pathways of apoptosis. Chin. J. Comp. Med. 2007, 17:5.
24. Beck V., Herold H., Benge A., Luber B., Hutzler P., Tschesche H., Kessler H., Schmitt M., Geppert H.G., Reuning U. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. Int. J. Biochem. Cell Biol. 2005, 37:590-603.
25. Lu D., Xie S., Sukkar M.B., Lu X., Scully M.F., Chung K.F. Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15. Am. J. Respir. Cell Mol. Biol. 2007, 37:494-500.
26. Sumanas S.L. Zebrafish as a model system for drug target screening and validation. Drug Discov. Today Targets 2004, 3:7.
27. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4:35-44.
28. Crawford A.D., Esguerra C.V., de Witte P.A. Fishing for drugs from nature: zebrafish as a technology platform for natural product discovery. Planta Med. 2008, 74:624-632.
29. Inohara N., Nunez G. Genes with homology to mammalian apoptosis regulators identified in zebrafish. Cell Death Differ. 2000, 7:509-510.